Early prediction of response of sorafenib on hepatocellular carcinoma by CT perfusion imaging: an animal study.
about
Phosphatidylcholine-specific phospholipase C inhibition reduces HER2-overexpression, cell proliferation and in vivo tumor growth in a highly tumorigenic ovarian cancer model.Application of dual-source CT perfusion imaging and MRI for the diagnosis of primary liver cancer.Dynamic Volume Assessment of Hepatocellular Carcinoma in Rat Livers Using a Clinical 3T MRI and Novel Segmentation.Prognostic value of perfusion CT in hepatocellular carcinoma treatment with sorafenib: comparison with mRECIST in longitudinal follow-up.
P2860
Early prediction of response of sorafenib on hepatocellular carcinoma by CT perfusion imaging: an animal study.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Early prediction of response o ...... sion imaging: an animal study.
@en
type
label
Early prediction of response o ...... sion imaging: an animal study.
@en
prefLabel
Early prediction of response o ...... sion imaging: an animal study.
@en
P2093
P2860
P356
P1476
Early prediction of response o ...... sion imaging: an animal study.
@en
P2093
P2860
P304
P356
10.1259/BJR.20130695
P407
P577
2014-01-27T00:00:00Z